An aspirin study from the Netherlands suggests that aspirin may actually improve survival in patients with colon cancer. Almost 4,500 people were included in the study that spanned nearly a decade. Of these, almost one in four took aspirin after their cancer diagnosis. Half had already been taking aspirin before the diagnosis and continued taking their low-dose aspirin pill after beginning treatment. One quarter of the colon cancer patients did not take aspirin. The researchers found that taking a baby aspirin pill daily reduced the risk of dying from colon cancer by up to 30 percent over the course of the decade.
[British Journal of Cancer, April 24, 2012]
The People's Perspective on Medicine